Back to User profile » Prof. Dr. Xuezhi Hao

Papers published by Prof. Dr. Xuezhi Hao:

Original Research

Bevacizumab Combined with Continuation of EGFR-TKIs in NSCLC Beyond Gradual Progression

Xu Z, Teng F, Hao X, Li J, Xing P

Cancer Management and Research 2022, 14:1891-1902

Published Date: 4 June 2022

Original Research

Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in EGFR-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients

Xu Z, Hao X, Wang Q, Wang J, Yang K, Wang S, Teng F, Li J, Xing P

Cancer Management and Research 2022, 14:863-873

Published Date: 1 March 2022

Study Protocol

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial

Liu YT, Hao XZ, Liu DR, Cheng G, Zhang SC, Xiao WH, Hu Y, Liu JF, He M, Ding CM, Zhang L, Wang J, Li H, Dong GL, Zhi XY, Li J, Shi YK

Cancer Management and Research 2020, 12:4633-4643

Published Date: 17 June 2020

Original Research

Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study

Mu Y, Xing P, Hao X, Wang Y, Li J

Cancer Management and Research 2019, 11:9243-9251

Published Date: 30 October 2019